Among the Korean subsidiaries of multinational pharmaceutical companies operating in Korea, 12 companies with an annual salary of over 100 million employees were found.
In addition, the company with the highest average annual salary for its employees was Gilead Science Korea with 165 million won.
As a result of analysis of the 2022 audit report of Korean corporations of multinational pharmaceutical companies in Korea by Comedy.com, it was found that the average annual salary of employees of the 36 companies surveyed was 99 million won, 1 million won less than 100 million won.
Last year, the annual salary of these companies was 94 million won.
Industry insiders explain that the average annual salary of employees of these multinational pharmaceutical companies is over 100 million won, given that the employee salaries listed in the audit report do not include welfare benefits and bonuses.
The average annual salary of employees of multinational pharmaceutical companies is about 34 million won more than the average annual salary of 65 million won for employees of domestic pharmaceutical companies.
Among the multinational pharmaceutical companies, 12 were surveyed with employee salaries exceeding 100 million won.
Gilead Science Korea had the most with 165 million won, followed by GlaxoSmithKline with 155 million won, Sanofi-Aventis Korea and Pfizer Korea with 131 million won each, Boehringer Ingelheim Korea with 123 million won, Roche Korea with Viatris Korea. 119 million won, Celgene 112 million won, Sanofi Pasteur 110 million won, Ferring Korea 105 million won, Kyowa Hako Kirin Korea and AbbVie Korea 103 million won each.
Gilead Science Korea, the largest multinational pharmaceutical company in terms of annual salary, is distributing Hepatitis B treatment Viread and Corona 19 treatment Remdesivir in Korea.
Meanwhile, among domestic pharmaceutical companies, the company with the highest employee annual salary was Yuhan with 89 million won, followed by Samjin Pharm with 78 million won, Ildong Pharm with 73 million won, Leeyeon Pharm Chong Kundang Ilyang Pharm with 72 million won, and Green Cross Hanmi Pharm with 71 million won.
By Kim Yong-joo, reporter [email protected]
Copyrightⓒ ‘Honest knowledge for health’ Comedy.com (https://kormedi.com) / Unauthorized reproduction-redistribution prohibited
Source: 코메디닷컴 by kormedi.com.
*The article has been translated based on the content of 코메디닷컴 by kormedi.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!